US Autoimmune Disease Diagnostics Market, Forecast to 2020

US Autoimmune Disease Diagnostics Market, Forecast to 2020

Systemic Autoimmune Diseases to Spur Double-digit Market Growth as Participants Look to Unmet Needs and Game-changing Strategies to Boost Revenues

RELEASE DATE
24-Feb-2016
REGION
North America
Research Code: 9AB9-00-48-00-00
SKU: HC02380-NA-MR_16502
$1,500.00
In stock
SKU
HC02380-NA-MR_16502
$1,500.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.

Table of Contents

Scope and Segmentation

Key Predictions: US Autoimmune Disease Diagnostics Market

Current Trends in the Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market—Overview

Key Companies to Watch

Ecosystem of the Autoimmune Disease Diagnostics Market

Significance of the Autoimmune Disease Diagnostics Market

Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates

Competitive Landscape

Key Diseases and Available Solutions in the US Market

Key Diseases and Available Solutions in the US Market (continued)

LDTs—Role in Autoimmune Disease Diagnostics

Segment Lifecycle Analysis by Disease

Overall Market Forecast

Overall Disease Segment Share

Competitive SWOT Analysis by Company

Competitive SWOT Analysis by Company (continued)

Where do the Opportunities Lie in this Market?

Pharma and Diagnostics Business Integration

Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels

Direct-to-Consumer Market: The Risk and The Opportunity

Localized Disease Diagnostics Segment Revenue

Growth Rate by Localized Autoimmune Diseases

Competitive Value Matrix—Localized Disease Diagnostics Segment

Autoimmune Tests—Role in Patient Continuum

Systemic Disease Diagnostics Segment Revenue

Growth Rate by Systemic Autoimmune Diseases

Competitive Value Matrix—Systemic Disease Diagnostics Segment

Autoimmune Tests—Role in Patient Continuum

Key Conclusions and Future Outlook

Legal Disclaimer

Celiac Disease-specific LDT Assays

Chron’s Disease-specific LDT Assays

RA-specific LDT Assays

Lupus-specific LDT Assays

IBD/IBS-specific LDT Assays

Others

Learn More—Next Steps

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as well as localized diseases, such as celiac, IBD, IBS, and Hashimoto's. Systemic diseases dominate the market due to their high prevalence in the United States and also because of the market participation of large diagnostics companies, such as Inova Diagnostics, Siemens Healthcare, Abbott Diagnostics, and Beckman Coulter. The localized disease segment is the fastest-growing, mainly due to celiac, as gluten intolerance in the United States is increasing at an exponential rate.
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number 9AB9-00-48-00-00
Keyword 1 Autoimmune Disease Diagnostics
Keyword 2 US Autoimmune Disease Diagnostics
Keyword 3 Disease Diagnostics
Is Prebook No